PeterM.KangMDFACC, FAHA

Associate Professor of Medicine, Beth Israel Deaconess Medical Center

Dr. Kang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3 Blackfan Cir
CLS 910
Boston, MA 02115
Phone+1 617-735-4290

Fax+1 617-735-4207

Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1995 - 1998
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1991 - 1994
George Washington University School of Medicine and Health SciencesClass of 1991

PubMed

5 citations
A Systematic Review on Advances in Management of Oxidative Stress-Associated Cardiovascular Diseases.
Soyeon Jin, Peter M Kang
Antioxidants. 2024-07-29
21 citations
Bilirubin Nanoparticles Protect Against Cardiac Ischemia/Reperfusion Injury in Mice.
Wen Ai, Soochan Bae, Qingen Ke, Shi Su, Ruijian Li
Journal of the American Heart Association. 2021-10-19
4 citations
The Prominin-1-Derived Peptide Improves Cardiac Function Following Ischemia.
Avner Adini, Irit Adini, Etty Grad, Yuval Tal, Haim D. Danenberg
International Journal of Molecular Sciences. 2021-05-13

Apoptosis Inducing Factor In Cardiac ApoptosisNational Heart, Lung, And Blood Institute2009–2010
Role Of Caspase-9 In HeartNational Heart, Lung, And Blood Institute2001–2005
Phosphoinositide-3 Kinase In Cardiac HypertrophyNational Heart, Lung, And Blood Institute2003–2004
Regulation Of Hypoxia Induced Cardiac ApoptosisNational Heart, Lung, And Blood Institute1998–2000